ClinicalTrials.Veeva

Menu

Effect of Different Centrifuge Values on Saliva High Sensitive C-Reactive Protein (Hs-CRP) Levels in Individuals With Different Smoking Amounts

I

Izmir Katip Celebi University

Status

Enrolling

Conditions

Smoking

Treatments

Diagnostic Test: saliva obtaining

Study type

Interventional

Funder types

Other

Identifiers

NCT06561971
2024-SAEK-0029

Details and patient eligibility

About

The purpose of this study; In periodontally healthy individuals, high sensitive c-reactive protein (hs-CRP) levels of non-smokers, smokers of less than 10 cigarettes per day and smokers of more than 10 cigarettes per day were measured at 15 rpm-10 min, 10 centrifuge values, which are frequently used in saliva studies. To determine the levels in saliva samples as a result of rpm-10 min and 10 rpm 6 min centrifugations and to determine the values at which a cytokine of this molecular weight should be centrifuged and to examine the possible correlation between these values and the clinical parameters of the amount of smoking. Materials and Methods: saliva samples were collected from 90 systemically healthy individuals who were non-smokers (N, n=30), light smokers <10 cigarettes per day (L, n=30) and heavy smokers >10 cigarettes per day (H, n=20). samples were taken. Full-mouth clinical periodontal measurements, including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), gingival index (GI), and plaque index (PI), were also recorded. Enzyme-linked immunosorbent assay (ELISA) was used to determine hs-CRP levels in biological samples.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Systemically healthy

  • Periodontally clinical healthy

  • At least 20 permanent teeth in the mouth

  • No medication for continuous use

  • Those who have not used antibiotics, anti-inflammatory and systemic corticosteroid drugs in the last 6 months.

  • Not in pregnancy or lactation period.

  • Not received periodontal treatment in the last 6 months

    • For the non-smoker group; person who does not smoke tobacco
    • For the light-smoker group; person who smokes less than 10 cigarettes a day
    • For heavy-smoker group; person who smokes more than 10 cigarettes a day

Exclusion criteria

  • Any oral or systemic disease
  • Regularly using a systemic medication
  • During pregnancy or lactation
  • Received periodontal treatment within the last 6 months.
  • Those who received antibiotic, anti-inflammatory or systemic corticosteroid medication in the last 6 months
  • Individual with periodontal disease

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 3 patient groups

Non-Smokers
Experimental group
Description:
Full-mouth clinical periodontal measurements recorded and saliva obtained.
Treatment:
Diagnostic Test: saliva obtaining
Light Smokers
Experimental group
Description:
Full-mouth clinical periodontal measurements recorded and saliva obtained.
Treatment:
Diagnostic Test: saliva obtaining
Heavy Smokers
Experimental group
Description:
Full-mouth clinical periodontal measurements recorded and saliva obtained.
Treatment:
Diagnostic Test: saliva obtaining

Trial contacts and locations

1

Loading...

Central trial contact

Mehmet Sağlam; Ece Özer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems